DAIHAN PHARMACEUTICAL revenue breakdown overview

DAIHAN PHARMACEUTICAL revenue for the last year amounted to 202.70 B KRW, the most of which — 156.49 B KRW — came from its highest performing source at the moment, Liquid Products, the year earlier bringing 151.20 B KRW. The greatest contribution to the revenue figure was made by South Korea — last year it brought DAIHAN PHARMACEUTICAL 204.19 B KRW, and the year before that — 195.91 B KRW.